Sign in

CIK 0001404644

  • Non-accelerated filer
  • Smaller reporting company

Neurogene Inc.

Sign in to watch
Ticker
NGNE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
980542593
Phone
+1 877-237-5020
Business address
535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
Former names
Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +9,143 $16.20 $148K 9,441,725
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +1,602 $15.13 $24K 1,137,167
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +15,148 $15.13 $229K 9,456,873
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +529 $15.62 $8K 1,137,696
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +5,006 $15.62 $78K 9,461,879
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +3,739 $16.31 $61K 1,141,435
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +35,360 $16.31 $577K 9,497,239
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +24,871 $17.60 $438K 1,166,306
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +235,169 $17.60 $4.1M 9,732,408
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +3,389 $17.76 $60K 1,169,695
2017-01-09 BAKER BROS. ADVISORS LP 10% owner Purchase +32,051 $17.76 $569K 9,764,459
2016-11-08 Troupin Barbara Chief Medical Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2016-09-20 BAKER BROS. ADVISORS LP 10% owner Purchase +294,707 $12.25 $3.6M 1,119,075
2016-09-20 BAKER BROS. ADVISORS LP 10% owner Purchase +2,476,348 $12.25 $30.3M 9,404,467
2016-09-20 BAKER BROS. ADVISORS LP 10% owner Purchase +12,550 $13.15 $165K 1,131,625
2016-08-03 Jenkins Abigail Chief Commercial Officer Grant or award · Stock Option (Right to Buy) +50,000 50,000
2016-05-09 Nolan Sean P. Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-05-09 Pelzer Robert Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-05-09 SIMPSON TODD E Director Grant or award · Stock Option (Right to Buy) +7,500 7,500
2016-05-09 LEVITT DANIEL J Director Grant or award · Stock Option (Right to Buy) +7,500 7,500

Page 16 of 20 · 397 trades